Copyright Reports & Markets. All rights reserved.

Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of B-Cell Chronic Lymphocytic Leukemia Treatment

      • 1.1 Definition of B-Cell Chronic Lymphocytic Leukemia Treatment
      • 1.2 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Type
        • 1.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 AMG-319
        • 1.2.3 ATTCK-20
        • 1.2.4 IDD-002
        • 1.2.5 JNJ-64052781
        • 1.2.6 Lenalidomide
        • 1.2.7 MAT-303
        • 1.2.8 MT-3724
        • 1.2.9 Others
      • 1.3 B-Cell Chronic Lymphocytic Leukemia Treatment Segment by Applications
        • 1.3.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.4 Global B-Cell Chronic Lymphocytic Leukemia Treatment Overall Market
        • 1.4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (2014-2025)
        • 1.4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production (2014-2025)
        • 1.4.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
        • 1.4.5 China B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)
        • 1.4.8 India B-Cell Chronic Lymphocytic Leukemia Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
      • 2.3 Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
      • 2.4 Industry Chain Structure of B-Cell Chronic Lymphocytic Leukemia Treatment

      3 Development and Manufacturing Plants Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of B-Cell Chronic Lymphocytic Leukemia Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 B-Cell Chronic Lymphocytic Leukemia Treatment Production and Capacity Analysis
      • 4.2 B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Analysis
      • 4.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 B-Cell Chronic Lymphocytic Leukemia Treatment Regional Market Analysis

      • 5.1 B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions
        • 5.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Regions
        • 5.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Regions
      • 5.2 B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Regions
      • 5.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
        • 5.3.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Production
        • 5.3.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
      • 5.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
        • 5.4.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Production
        • 5.4.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
      • 5.5 China B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
        • 5.5.1 China B-Cell Chronic Lymphocytic Leukemia Treatment Production
        • 5.5.2 China B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
      • 5.6 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
        • 5.6.1 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Production
        • 5.6.2 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
      • 5.7 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
        • 5.7.1 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Production
        • 5.7.2 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export
      • 5.8 India B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis
        • 5.8.1 India B-Cell Chronic Lymphocytic Leukemia Treatment Production
        • 5.8.2 India B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export

      6 B-Cell Chronic Lymphocytic Leukemia Treatment Segment Market Analysis (by Type)

      • 6.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Production by Type
      • 6.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Type
      • 6.3 B-Cell Chronic Lymphocytic Leukemia Treatment Price by Type

      7 B-Cell Chronic Lymphocytic Leukemia Treatment Segment Market Analysis (by Application)

      • 7.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Application
      • 7.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Market Share by Application (2014-2019)

      8 B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers Analysis

      • 8.1 AB Science SA
        • 8.1.1 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.1.2 AB Science SA Product Introduction, Application and Specification
        • 8.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Amgen Inc.
        • 8.2.1 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.2.2 Amgen Inc. Product Introduction, Application and Specification
        • 8.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Celgene Corporation
        • 8.3.1 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.3.2 Celgene Corporation Product Introduction, Application and Specification
        • 8.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Dynavax Technologies Corporation
        • 8.4.1 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.4.2 Dynavax Technologies Corporation Product Introduction, Application and Specification
        • 8.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Eisai
        • 8.5.1 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.5.2 Eisai Product Introduction, Application and Specification
        • 8.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Elsalys Biotech SAS
        • 8.6.1 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.6.2 Elsalys Biotech SAS Product Introduction, Application and Specification
        • 8.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 F. Hoffmann-La Roche Ltd.
        • 8.7.1 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.7.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
        • 8.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 iDD biotech SAS
        • 8.8.1 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.8.2 iDD biotech SAS Product Introduction, Application and Specification
        • 8.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Immunomedics, Inc.
        • 8.9.1 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.9.2 Immunomedics, Inc. Product Introduction, Application and Specification
        • 8.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Johnson & Johnson
        • 8.10.1 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production Sites and Area Served
        • 8.10.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Juno Therapeutics Inc.
      • 8.12 Molecular Templates Inc.
      • 8.13 Noxxon Pharma AG

      9 Development Trend of Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment Market

      • 9.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend Analysis
        • 9.1.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 B-Cell Chronic Lymphocytic Leukemia Treatment Regional Market Trend
        • 9.2.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
        • 9.2.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
        • 9.2.3 China B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
        • 9.2.4 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
        • 9.2.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Forecast 2019-2025
      • 9.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend (Product Type)
      • 9.4 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 B-Cell Chronic Lymphocytic Leukemia Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global B-Cell Chronic Lymphocytic Leukemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on B-Cell Chronic Lymphocytic Leukemia Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Chronic Lymphocytic Leukemia Treatment market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Chronic Lymphocytic Leukemia Treatment in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their B-Cell Chronic Lymphocytic Leukemia Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        AB Science SA
        Amgen Inc.
        Celgene Corporation
        Dynavax Technologies Corporation
        Eisai
        Elsalys Biotech SAS
        F. Hoffmann-La Roche Ltd.
        iDD biotech SAS
        Immunomedics, Inc.
        Johnson & Johnson
        Juno Therapeutics Inc.
        Molecular Templates Inc.
        Noxxon Pharma AG

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        AMG-319
        ATTCK-20
        IDD-002
        JNJ-64052781
        Lenalidomide
        MAT-303
        MT-3724
        Others

        Segment by Application
        Clinic
        Hospital
        Others

        Buy now